Affymetrix AFFX
-
6 Small Cap Stocks With Plenty Of Cash On Hand And Strong Expected Growth
By ZetaKap : Small-cap stocks tend to offer investors greater growth opportunities than large-cap alternatives, although this comes with its fair share of added risk. Are you looking for small-caps? Do you feel better knowing your favorite companies have enough cash to cover their operating ...
-
Affymetrix ( AFFX ): Q1 EPS of -$0.06 beats by $0.04. Revenue of $58.4M (-11.5% Y/Y) misses by $6M. (PR)
Affymetrix ( AFFX ): Q1 EPS of -$0.06 beats by $0.04 . Revenue of $58.4M (-11.5% Y/Y) misses by $6M . ( PR ) Post your comment!
-
Market's Reaction To M&A Possibilities In Sequencing Companies
By Dave Westenberg: On January 24, Roche ( RHHBY.PK ) made an unsolicited offer directly to the shareholders of Illumina ( ILMN ) for $44.50 a share. The stock jumped the next day to around $55 per share. The offer was rejected and a poison pill resulted because of Illumina's advice from Goldman ...
-
As Amgen Surges, Bristol Hunts For Takeover Targets
… other hand, trades at a respective 15.1x and 16.8x past and forward earnings. Smaller firms 3SBio ( SSRX ) and Affymax ( AFFX ) echo the upside stories through focusing on markets with unmet demand. For the year to date, the former has gained 14.4 …
-
Affymetrix ( AFFX ) +3.7% premarket after the company says China has cleared its first microarray platform for in vitro diagnostics to accelerate personalized medicine. AFFX says China has more than ...
Affymetrix ( AFFX ) +3.7% premarket after the company says China has cleared its first ..... platform for in vitro diagnostics to accelerate personalized medicine. AFFX says China has more than 2,000 clinical centers that will now have access …
-
More on Affymetrix ( AFFX ): Q4 posts a big miss as as losses increase on significantly lower revenue across all segments. Product revenue was just $58M for the quarter, compared to Q4 2010 when came ...
More on Affymetrix ( AFFX ): Q4 posts a big miss as as losses increase on significantly lower revenue across all segments. Product revenue was just $58M for the quarter, compared to Q4 2010 when came in at $71.9M. Shares -9.6% AH. Post your comment!
-
Affymetrix ( AFFX ): Q4 EPS of -$0.21 misses by $0.14. Revenue of $65.1M (+-23.3% Y/Y) in-line. Shares -9.8% AH. (PR)
Affymetrix ( AFFX ): Q4 EPS of -$0.21 misses by $0.14 . Revenue of $65.1M (+-23.3% Y/Y) in-line. Shares -9.8% AH. ( PR ) Post your comment!
-
Behind Roche's Pharmaceutical Shake Up
By Jessica King Holden : Roche's ( RHHBY.PK ) hostile $5.7 billion bid for genetic diagnostic company Illumina ( ILMN ) has opened a pandora's box of genetic information. The pharmaceutical giant appears to be aligning itself to become a one-stop-shop for pharmaceutical success, avoiding the ...
-
Affymetrix ([[ AFFX ]] -2.4%) announces a collaboration with BGI to expand research and molecular breeding tools for enhancing plant, crop, and livestock production outcomes.
Affymetrix ( AFFX -2.4% ) announces a collaboration with BGI to expand research and molecular breeding tools for enhancing plant, crop, and livestock production outcomes. Post your comment!
-
Affymetrix Shares Primed For A Rebound
… After seeing a higher than expected drop, shares of Affymetrix ( AFFX ) appear to be showing some a bottom at these price ..... both wondering if the stock will finally rebound . Affymetrix Inc is engaged in creating breakthrough tools that …